You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

Medline stock is a little too expensive to buy post IPO, Jim Cramer says ○

found 2025 › Dec › 18 (Thu) @ 10:45 UTC

a story from CNBC ⚠️ › Top News

○ Neutral overall

0.00 negativity

0.00 neutrality

0.00 positivity